David Scott Jones, SVP & Chief Commercial Officer at EyePoint Pharmaceuticals, Inc. (EYPT), sold 11,600 shares at $25.01 ($290K) on 2024-01-24, disclosed to the SEC on 2024-01-26.
Scheduled sale ($290k) by SVP & Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.01 | 5,600 | $140K | 48.3% |
| 2 | $25.01 | 5,700 | $143K | 49.1% |
| 3 | $25.00 | 300 | $8K | 2.6% |
| Total | $25.01 avg | 11,600 | $290K | 100% |
| Filing → |
| EYPT | SELL | 2024-01-24 | $1.6M | — | Filing → |